Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics.

Front Mol Biosci · 2024 · PMC11736410 · PMID 39822391

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nearly significantno p-value reported

The primary tumor site distribution was nearly significant, with a higher proportion of HER2-patients having bladder tumors (64.56%) compared to HER2+ patients (77.85%) and a lower proportion of HER2-patients having ureteral (24.05%) and renal pelvis (11.39%) tumors compared to HER2+ patients (12.66% and 9.49%, respectively) ( p = 0.061).

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.